Related references
Note: Only part of the references are listed.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis
Z. Betteridge et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Severe edematous dermatomyositis
R. Goussot et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2016)
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes
L. G. Rider et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies
Naoki Mugii et al.
PLOS ONE (2016)
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change
C. O. Anyanwu et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis
Iago Pinal-Fernandez et al.
JOURNAL OF RHEUMATOLOGY (2015)
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort
Levente Bodoki et al.
AUTOIMMUNITY REVIEWS (2014)
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
Sarah L. Tansley et al.
RHEUMATOLOGY (2014)
Dermatomyositis presenting with severe subcutaneous edema: Five additional cases and review of the literature
Jose C. Milisenda et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Identification of Clinical Features and Autoantibodies Associated With Calcinosis in Dermatomyositis
Antonia Valenzuela et al.
JAMA DERMATOLOGY (2014)
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
David F. Fiorentino et al.
ARTHRITIS AND RHEUMATISM (2013)
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
Lisa G. Rider et al.
MEDICINE (2013)
Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
Yuki Ichimura et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2
Asuka Ishikawa et al.
RHEUMATOLOGY (2012)
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
Angela Ceribelli et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Autoantibodies to a 140-kd Protein in Juvenile Dermatomyositis Are Associated With Calcinosis
H. Gunawardena et al.
ARTHRITIS AND RHEUMATISM (2009)
Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein
Graciela Espada et al.
JOURNAL OF RHEUMATOLOGY (2009)
Anasarca: not a nephrotic syndrome but dermatomyositis
Magdy Zedan et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Dynamic regulation of p53 subnuclear localization and senescence by MORC3
Keiko Takahashi et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects
RD Sontheimer
DERMATOLOGIC CLINICS (2002)
Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activity
JP Mitchell et al.
JOURNAL OF PEDIATRICS (2001)
Share Paper
